Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DAZAP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SH3BP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SRSF7 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | SRSF3 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |